Filed: 8/14/2026ACC: 0001622627-26-000022
📋 What this filing means
ROSALIND ADVISORS, INC. filed this quarterly 13F‑HR report disclosing 35 equity positions with a total reported market value of $269.20M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
35
Positions
$269.20M
Total AUM (reported)
46.02M
Total Shares
Allocation by class
COM NEW$135.14M50.2%
COM$114.14M42.4%
SHS NEW$11.01M4.1%
SPONSORED ADS$2.78M1.0%
ORDINARY SHARES$2.48M0.9%
PUT$2.46M0.9%
COM CL A$684.0K0.3%
Portfolio Concentration
Top 3$98.86M36.7%
4–10$100.45M37.3%
11–25$64.69M24.0%
Rest$5.20M1.9%
Top 3 weight
36.7%
Top 10 weight
74.0%
Voting Authority Distribution
Total shares with voting rights: 46.02M
Sole
Full voting authority
46.02M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole35
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings35
Rows:
DELCATH SYSTEMS, INC.
SOLEShares3.30M
TypeSH
Market value$41.55M
15.44%
Sole
3.30M
Shared
0.00
None
0.00
FENNEC PHARMACEUTICALS INC
SOLEShares3.19M
TypeSH
Market value$34.27M
12.73%
Sole
3.19M
Shared
0.00
None
0.00
XERIS BIOPHARMA HOLDINGS INC
SOLEShares2.91M
TypeSH
Market value$23.04M
8.56%
Sole
2.91M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares3.18M
TypeSH
Market value$19.58M
7.27%
Sole
3.18M
Shared
0.00
None
0.00
VERASTEM INC
SOLEShares3.99M
TypeSH
Market value$15.23M
5.66%
Sole
3.99M
Shared
0.00
None
0.00
X4 PHARMACEUTICALS INC
SOLEShares3.21M
TypeSH
Market value$15.01M
5.58%
Sole
3.21M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares988.23K
TypeSH
Market value$14.13M
5.25%
Sole
988.23K
Shared
0.00
None
0.00
CYBIN INC
SOLEShares1.96M
TypeSH
Market value$12.93M
4.80%
Sole
1.96M
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares648.60K
TypeSH
Market value$11.94M
4.44%
Sole
648.60K
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares200K
TypeSH
Market value$11.63M
4.32%
Sole
200K
Shared
0.00
None
0.00
MEDIWOUND LTD
SOLEShares749.05K
TypeSH
Market value$11.01M
4.09%
Sole
749.05K
Shared
0.00
None
0.00
CELLDEX THERAPEUTICS INC
SOLEShares200K
TypeSH
Market value$7.44M
2.76%
Sole
200K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares721.50K
TypeSH
Market value$7.22M
2.68%
Sole
721.50K
Shared
0.00
None
0.00
PROFOUND MEDICAL CORP
SOLEShares828.12K
TypeSH
Market value$5.51M
2.05%
Sole
828.12K
Shared
0.00
None
0.00
TALPHERA INC
SOLEShares5.17M
TypeSH
Market value$5.32M
1.98%
Sole
5.17M
Shared
0.00
None
0.00
ATEA PHARMACEUTICALS INC
SOLEShares1.07M
TypeSH
Market value$4.98M
1.85%
Sole
1.07M
Shared
0.00
None
0.00
MYOMO INC
SOLEShares3.64M
TypeSH
Market value$3.78M
1.41%
Sole
3.64M
Shared
0.00
None
0.00
OVID THERAPEUTICS INC
SOLEShares1.11M
TypeSH
Market value$2.98M
1.11%
Sole
1.11M
Shared
0.00
None
0.00
NEURAXIS INC
SOLEShares508.06K
TypeSH
Market value$2.97M
1.10%
Sole
508.06K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares20.87K
TypeSH
Market value$2.78M
1.03%
Sole
20.87K
Shared
0.00
None
0.00
INSPIREMD INC
SOLEShares3.91M
TypeSH
Market value$2.73M
1.02%
Sole
3.91M
Shared
0.00
None
0.00
REGENTIS BIOMATERIALS LTD
SOLEShares701.68K
TypeSH
Market value$2.48M
0.92%
Sole
701.68K
Shared
0.00
None
0.00
SELLAS LIFE SCIENCES GROUP INC
SOLEShares568.70K
TypeSH
Market value$2.30M
0.86%
Sole
568.70K
Shared
0.00
None
0.00
POLYPID LTD
SOLEShares389.45K
TypeSH
Market value$1.98M
0.73%
Sole
389.45K
Shared
0.00
None
0.00
BIOFRONTERA INC
SOLEShares1.28M
TypeSH
Market value$1.21M
0.45%
Sole
1.28M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
DELCATH SYSTEMS, INC.SOLE | COM NEW | 3.30M | SH | $41.55M 15.44% | 3.30M | 0.00 | 0.00 |
FENNEC PHARMACEUTICALS INCSOLE | COM | 3.19M | SH | $34.27M 12.73% | 3.19M | 0.00 | 0.00 |
XERIS BIOPHARMA HOLDINGS INCSOLE | COM | 2.91M | SH | $23.04M 8.56% | 2.91M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 3.18M | SH | $19.58M 7.27% | 3.18M | 0.00 | 0.00 |
VERASTEM INCSOLE | COM NEW | 3.99M | SH | $15.23M 5.66% | 3.99M | 0.00 | 0.00 |
X4 PHARMACEUTICALS INCSOLE | COM NEW | 3.21M | SH | $15.01M 5.58% | 3.21M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 988.23K | SH | $14.13M 5.25% | 988.23K | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 1.96M | SH | $12.93M 4.80% | 1.96M | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM NEW | 648.60K | SH | $11.94M 4.44% | 648.60K | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 200K | SH | $11.63M 4.32% | 200K | 0.00 | 0.00 |
MEDIWOUND LTDSOLE | SHS NEW | 749.05K | SH | $11.01M 4.09% | 749.05K | 0.00 | 0.00 |
CELLDEX THERAPEUTICS INCSOLE | COM NEW | 200K | SH | $7.44M 2.76% | 200K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 721.50K | SH | $7.22M 2.68% | 721.50K | 0.00 | 0.00 |
PROFOUND MEDICAL CORPSOLE | COM NEW | 828.12K | SH | $5.51M 2.05% | 828.12K | 0.00 | 0.00 |
TALPHERA INCSOLE | COM NEW | 5.17M | SH | $5.32M 1.98% | 5.17M | 0.00 | 0.00 |
ATEA PHARMACEUTICALS INCSOLE | COM | 1.07M | SH | $4.98M 1.85% | 1.07M | 0.00 | 0.00 |
MYOMO INCSOLE | COM NEW | 3.64M | SH | $3.78M 1.41% | 3.64M | 0.00 | 0.00 |
OVID THERAPEUTICS INCSOLE | COM | 1.11M | SH | $2.98M 1.11% | 1.11M | 0.00 | 0.00 |
NEURAXIS INCSOLE | COM | 508.06K | SH | $2.97M 1.10% | 508.06K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 20.87K | SH | $2.78M 1.03% | 20.87K | 0.00 | 0.00 |
INSPIREMD INCSOLE | COM | 3.91M | SH | $2.73M 1.02% | 3.91M | 0.00 | 0.00 |
REGENTIS BIOMATERIALS LTDSOLE | ORDINARY SHARES | 701.68K | SH | $2.48M 0.92% | 701.68K | 0.00 | 0.00 |
SELLAS LIFE SCIENCES GROUP INCSOLE | PUT | 568.70K | SH | $2.30M 0.86% | 568.70K | 0.00 | 0.00 |
POLYPID LTDSOLE | COM | 389.45K | SH | $1.98M 0.73% | 389.45K | 0.00 | 0.00 |
BIOFRONTERA INCSOLE | COM NEW | 1.28M | SH | $1.21M 0.45% | 1.28M | 0.00 | 0.00 |
Page 1 of 2